PV, ET and MF are effectively treated during the COVID-19 pandemic - ask the experts about how best to manage your MPN.

Idasanutlin is active in the treatment of PV and ET and is currently being evaluated in a global phase 2 trial.

Thalidomide - Jakafi Combination may be Effective for Treatment of Myelofibrosis Associated Low Blood Counts

Understand the symptoms, diagnosis, treatment & management of Polycythemia Vera.

In addition to improving long term survival Jakafi® improves MF caused fatigue, spleenomegaly and kidney function.

Leading cancer centers create combined social community with MPNRF PV Reporter & Cancer Connect to support MPN patients

Dr. Ruben Mesa, Mays Cancer Center answered questions about the management of polycythemia vera and myelofibrosis.

Research suggests conflicting results with Interferon treatment for polycythemia vera and essential thrombocythemia.